Replication of the human immunodeficiency virus (HIV-1) requires an ordered pattern of viral gene expression. [1] This process is dependent upon the association of Rev, an essential viral regulatory protein, with its respective RNA binding site, the Rev-response-element (RRE). [2] The RRE is necessary for the active export of unspliced genomic viral RNA from the nucleus and serves as part of the envelope ± protein coding sequence. [2] This dual function makes the Rev ± RRE binding event an attractive target for therapeutic intervention because the evolution of resistant variants may be prevented or impeded. Small molecules that specifically bind the RRE and preclude or competitively displace the Rev protein are therefore promising antiviral candidates. [3±5] Aminoglycoside antibiotics have been shown to competitively block the binding of the Rev protein to the RRE, thus providing an important precedent for the use of low molecular weight ligands to target viral RNA sites. [3,6] These natural antibiotics, however, bind the RRE with relatively low affinity and specificity. [7] Since aminoglycosides and most other RNA ligands appear to recognize certain RNA folds, rather than specific RNA sequences, the design and discovery of RNA ligands is a challenging and empirical process. [7b] Commonly employed RNA-binding assays are limited in their ability to probe both the affinity and specificity of potential binders. [7a, 8, 9] New approaches that allow the rapid determination of both the RNA affinity and specificity of small molecules will assist in the discovery of new lead compounds and advance the understanding of RNA recognition. To this end, we report the assembly of an immobilized RNA ± protein complex and demonstrate its application to the discovery and characterization of new RNA binders.The high-affinity Rev binding site within the RRE is the purine-rich bulge shown in Figure 1. [10] The arginine-rich segment, Rev 34±50 , binds the RRE with a dissociation constant similar to that of the full-length Rev protein. [11] We have developed an assay based on the competition between potential RNA binders and a fluorescent Rev peptide (ªRev-Flº) for binding to an immobilized RRE fragment. The assay identifies small molecules that specifically interfere with Rev ± RRE binding (Figure 1). Ligands that bind to the [1] Magnetic Molecular Materials